Other News To Note
• Cancer Research UK's Cancer Research Institute in London reported that a combination of gemcitabine and drug candidate MRK003 killed cancer cells in mice with a greater effect than either drug alone. The drug is being tested in a clinical trial carried out in partnership with Cambridge University Hospitals Foundation Trust. The drug combo may have application in pancreatic cancer.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5476
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST